Insider · CIK 0001389147

DILLY STEPHEN GEORGE

Reports to the SEC for 5 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001389147

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	CDXSCODEXIS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+66.4K sh	—	—	66,350
2025-11-11	CDXSCODEXIS, INC.A Award	Director	AAward	+50K sh	$1.85	+$92.4K	727,053
2025-02-05	CDXSCODEXIS, INC.A Award	Director	AAward	+88.8K sh	—	—	673,053
2025-02-05	CDXSCODEXIS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+533K sh	—	—	532,500
2024-01-01	CDXSCODEXIS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+861K sh	—	—	860,500
2024-01-01	CDXSCODEXIS, INC.A Award	Director	AAward	+143K sh	—	—	582,303
2023-09-08	CDXSCODEXIS, INC.P Purchase	Director	PPurchase	+58.5K sh	$1.73	+$101K	438,878
2023-03-08	CDXSCODEXIS, INC.S Sale	Director	SSale	−27K sh	$4.56	−$123K	380,399
2023-03-07	CDXSCODEXIS, INC.S Sale	Director	SSale	−28.1K sh	$4.60	−$129K	407,386
2023-02-21	CDXSCODEXIS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+338K sh	—	—	337,500
2023-02-21	CDXSCODEXIS, INC.A Award	Director	AAward	+113K sh	—	—	146,474
2023-02-08	CDXSCODEXIS, INC.A Award	Director	AAward	+289K sh	—	—	435,474
2022-08-01	CDXSCODEXIS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+700K sh	—	—	700,000
2022-07-01	Sierra Oncology, Inc.D Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−5,000 sh	$55.00	−$275K	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−165K sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−92K sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−260K sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−520K sh	—	—	0
2022-06-17	Sierra Oncology, Inc.Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+65K sh	—	—	65,000
2022-06-14	CDXSCODEXIS, INC.A Award	Director	AAward	+11.3K sh	—	—	33,974
2022-03-14	Sierra Oncology, Inc.Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+165K sh	—	—	165,000
2022-01-28	Sierra Oncology, Inc.Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+65K sh	—	—	65,000
2021-06-15	CDXSCODEXIS, INC.A Award	Director	AAward	+4,796 sh	—	—	22,701
2021-05-19	Sierra Oncology, Inc.P Purchase	Director, CEO and President	PPurchase	+5,000 sh	$17.83	+$89.1K	5,000
2021-03-15	Sierra Oncology, Inc.Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+92K sh	—	—	92,000
2020-06-16	CDXSCODEXIS, INC.A Award	Director	AAward	+17.9K sh	—	—	17,905
2020-06-01	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director, CEO and President	AAward	+520K sh	—	—	520,000
2020-05-18	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+10K sh	—	—	15,000
2020-05-18	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-05-18	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+2,500 sh	—	—	7,500
2020-05-18	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-03-19	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right-to-Buy)M Exercise/Conversion	Director	MExercise/Conversion	−35K sh	—	—	0
2020-03-19	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+35K sh	$5.42	+$190K	40,000
2020-03-19	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−35K sh	$6.00	−$210K	5,000
2020-03-16	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right-to-Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	35,000
2020-03-16	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−15K sh	$6.02	−$90.3K	5,000
2020-03-16	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$5.42	+$81.3K	20,000
2019-06-10	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-06-10	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+2,500 sh	—	—	5,000
2018-06-11	Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−29.5K sh	—	—	295,942
2018-06-11	Aimmune Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−29.5K sh	$30.83	−$908K	315,308
2018-06-11	Aimmune Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+29.5K sh	$3.02	+$89K	344,765
2018-06-11	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-06-11	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+2,500 sh	—	—	2,500
2018-06-08	Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−42.1K sh	—	—	325,399
2018-06-08	Aimmune Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−42.1K sh	$30.70	−$1.29M	315,308
2018-06-08	Aimmune Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+42.1K sh	$3.02	+$127K	357,414
2018-06-07	Aimmune Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−500 sh	$31.58	−$15.8K	315,308
2018-06-07	Aimmune Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−32.1K sh	$30.95	−$993K	315,808
2018-06-07	Aimmune Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+32.6K sh	$3.02	+$98.5K	347,906

Recent filings

Accepted (ET)
Jun 184
DILLY STEPHEN GEORGE0001610717-26-000240
SEC(opens sec.gov)
Nov 124
DILLY STEPHEN GEORGE0001610717-25-000374
SEC(opens sec.gov)
Feb 74
DILLY STEPHEN GEORGE0000905148-25-000438
SEC(opens sec.gov)
Jan 24
DILLY STEPHEN GEORGE0000905148-24-000029
SEC(opens sec.gov)
Sep 124
DILLY STEPHEN GEORGE0000905148-23-000900
SEC(opens sec.gov)
Mar 94
DILLY STEPHEN GEORGE0001567619-23-004772
SEC(opens sec.gov)
Feb 214
DILLY STEPHEN GEORGE0001567619-23-003441
SEC(opens sec.gov)
Aug 34
DILLY STEPHEN GEORGE0001567619-22-014899
SEC(opens sec.gov)
Jul 14
DILLY STEPHEN GEORGE0001209191-22-040252
SEC(opens sec.gov)
Jun 174
DILLY STEPHEN GEORGE0001209191-22-037833
SEC(opens sec.gov)
Jun 164
DILLY STEPHEN GEORGE0001567619-22-012978
SEC(opens sec.gov)

Companies

Address

C/O CODEXIS, INC. 200 PENOBSCOT DRIVE

REDWOOD CITY, CA, 94063